The value of natriuretic peptide testing for the diagnosis and prevention of heart failure in high-risk populations-Reference-Cited by-同舟云学术

The value of natriuretic peptide testing for the diagnosis and prevention of heart failure in high-risk populations

Published:2024-08-19 Issue:3 Volume:5 Page:231-232
ISSN:2628-491X
Container-title:Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
language:en
Short-container-title:

Author:

Gruson Damien¹²³

Affiliation:

1. Department of Laboratory Medicine , 70492 Cliniques Universitaires St-Luc and Université Catholique de Louvain , Brussels , Belgium

2. Pôle de recherche en Endocrinologie, Diabète et Nutrition , Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires St-Luc and UCLouvain , Brussels , Belgium

3. Division on Emerging Technologies of the International Federation of Laboratory Medicine (IFCC) , Milan , Italy

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/almed-2024-0121/pdf

Reference6 articles.

1. Bayes-Genis, A, Docherty, KF, Petrie, MC, Januzzi, JL, Mueller, C, Anderson, L, et al.. Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: a clinical consensus statement from the Heart Failure Association of the ESC. Eur J Heart Fail 2023;25:1891–8. https://doi.org/10.1002/ejhf.3036.

2. Pop-Busui, R, Januzzi, JL, Bruemmer, D, Butalia, S, Green, JB, Horton, WB, et al.. Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association. Diabetes Care 2022;45:1670–90. https://doi.org/10.2337/dci22-0014.

3. Gruson, D, Hammerer-Lercher, A, Collinson, P, Duff, C, Baum, H, Pulkki, K, et al.. The multidimensional value of natriuretic peptides in heart failure, integrating laboratory and clinical aspects. Crit Rev Clin Lab Sci 2024;1–15. https://doi.org/10.1080/10408363.2024.2319578.

4. Lapi, F, Marconi, E, Medea, G, Parretti, D, Piccinni, C, Pietro, MA, et al.. To support the use of NT-proBNP to better detect heart failure in patients with type 2 diabetes. Endocrine 2023;82:42–6. https://doi.org/10.1007/s12020-023-03419-2.

5. Patel, KV, Segar, MW, Klonoff, DC, Khan, MS, Usman, MS, Lam, CSP, et al.. Optimal screening for predicting and preventing the risk of heart failure among adults with diabetes without atherosclerotic cardiovascular disease: a pooled cohort analysis. Circulation 2024;149:293–304. https://doi.org/10.1161/circulationaha.123.067530.